TriArm Therapeutics
PrivateCompany Overview
TriArm Therapeutics operates in Healthcare & Life Sciences and is based in Taiwan. It was founded in 2019.
TriArm Therapeutics is a biotechnology company focused on the development of innovative cell and gene therapies, specifically next-generation CAR-T treatments using its proprietary non-viral FIT™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TriArm Therapeutics Comparables
Compare TriArm Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RORA Biologics | 80% |
For institutional investors. Book with your work email.
TriArm Therapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 4, 2024
Grew 100% QoQ from 4 to 8 employees.
- Nov 26, 2024
Grew 100% QoQ from 4 to 8 employees.
For institutional investors. Book with your work email.
TriArm Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TriArm Therapeutics's valuation, stock price, and market status.
Is TriArm Therapeutics a public or private company?
TriArm Therapeutics is a private company.
What is the current stock price of TriArm Therapeutics?
TriArm Therapeutics is a private company, so its shares have no public market price. Caplight tracks TriArm Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TriArm Therapeutics worth (valuation)?
Valuation information for TriArm Therapeutics is not publicly available.
Can I buy TriArm Therapeutics stock?
TriArm Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TriArm Therapeutics's last funding round?
Funding round information for TriArm Therapeutics is not publicly available.
Who are the main investors in TriArm Therapeutics?
Investor information for TriArm Therapeutics is not publicly disclosed.
Will TriArm Therapeutics IPO soon?
No public IPO plans have been announced for TriArm Therapeutics.
How can I track TriArm Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in TriArm Therapeutics's shares on secondary markets.